关注
Dr. Sudha Vengurlekar
Dr. Sudha Vengurlekar
Professor of Medicinal Chemistry, Faculty of Pharmacy, Oriental University, Indore
在 orientaluniversity.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Transdermal delivery by iontophoresis
S Rawat, S Vengurlekar, B Rakesh, S Jain, G Srikarti
Indian journal of pharmaceutical sciences 70 (1), 5, 2008
1262008
Prescribing pattern of antidiabetic drugs in Indore city hospital
S Vengurlekar, P Shukla, P Patidar, R Bafna, S Jain
Indian journal of pharmaceutical sciences 70 (5), 637, 2008
782008
Efficacy of some natural compounds as antifungal agents
S Vengurlekar, R Sharma, P Trivedi
Pharmacognosy reviews 6 (12), 91, 2012
502012
A Study on the Biological Activity of 2-thioxo-imidazolidin-4-ones
S Vengurlekar, R Sharma, P Trivedi
Letters in Drug Design & Discovery 9 (5), 549-555, 2012
342012
Quantitative structure activity relationship studies of diarylimidazoles as selective COX-2 inhibitors
MR Yadav, DS Puntambekar, KP Sarathy, S Vengurlekar, R Giridhar
CSIR, 2006
162006
Biomedical applications of nanoparticles
AM Grumezescu
William Andrew, 2019
152019
Prescribing Pattern of Anti diabetic Drugs in Indore City Hospital
V Sudha, P Shukla, P Patidar, R Bafna, S Jain
Indian J Pharm Sci 70 (5), 637-40, 2008
122008
Nano drug delivery strategies for the treatment of cancers
AK Yadav, U Gupta, R Sharma
Academic Press, 2020
102020
Synthesis and Evaluation of some Thiazole derivatives as an Antifungal agent.
S Vengurlekar, S Prachand, S Jain, R Gupta
International Journal of Pharmacy & Life Sciences 5 (5), 2014
92014
Two-and three-dimensional QSAR studies on benzyl amide-ketoacid inhibitors of HIV integrase and their reduced analogues
S Vengurlekar, R Sharma, P Trivedi
Medicinal chemistry research 19, 1106-1120, 2010
82010
Elevating toward a new innovation: Carbon nanotubes (CNTs)
S Vengurlekar, SC Chaturvedi
Biomedical Applications of Nanoparticles, 271-294, 2019
42019
Nanoparticles and lung cancer
S Vengurlekar, SC Chaturvedi
Nano Drug Delivery Strategies for the Treatment of Cancers, 107-118, 2021
22021
Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting
V Rajoriya, R Gupta, S Vengurlekar, US Singh
International Journal of Pharmaceutics, 123986, 2024
12024
Natural Products for the Management of Arthritic Disorders
RK Gautam, L Deb, K Dua
Bentham Science Publishers, 2022
12022
Synthesis, Antifungal Activity and Molecular Docking Studies on N-(Substituted-benzylidineamine)-3-cycloalkylidine-thiosemicarbazide Derivatives
S Vengurlekar, R Sharma, P Trivedi
International Journal of Drug Delivery 6 (2), 99, 2014
12014
Synthesis, Antifungal Evaluation and Molecular Docking Studies on 2-Thioxoimidazolidin-4-One Derivatives
S Vengurlekar, R Sharma, P Trivedi
Medicinal Chemistry 9 (3), 459-473, 2013
12013
Insilico Docking Analysis of Some Novel Quinazoline Derivatives as Potent Antimicrobial Agent
N Singh, K Daniel, SK Jain, S Vengurlekar
Current Science 4 (3), 545-552, 2024
2024
A Review Article on Cleaning Validation
A Shrivastava, S Vengurlekar, SK Jain
Jour Med Resh and Health Sci 7 (4), 3066-3072, 2024
2024
Synthesis, and Invitro Antihelmintic Activity of Beta-Carboline Derivatives
P Choudhary, K Daniel, SK Jain, S Vengurlekar
Current Science 4 (2), 521-525, 2024
2024
Development and Validation of Analytical Method of Raltegravir, An Antiviral Drug
S Patidar, S Vengurlekar, SK Jain
Asian Journal of Pharmaceutical Analysis 14 (1), 21-25, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20